Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 13,965Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 35DECIPHERA PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 11426390

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3416

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-12

blank

02

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 11433056

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3423

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-12

blank

03

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 12023328

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3957

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-12-30

blank

04

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 12023327

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3958

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-12

blank

05

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 12023326

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3959

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-12

blank

06

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 12023325

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3960

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-12

blank

07

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 11529336

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3382

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-12

blank

08

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 11534432

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3442

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-08-12

blank

09

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 11969415

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3219

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-12-30

blank

10

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

RIPRETINIB

US Patent Number : 11969414

Drug Substance Claim :

Drug Product Claim :

Application Number : 213973

Patent Use Code : U-3897

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-02-08

blank